Daniel D. Shoemaker
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel D. Shoemaker
The proxy statement of Fate Therapeutics Inc reports total compensation of $2,818,586 for Daniel D. Shoemaker in fiscal 2019, including a base salary of $375,000.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Fate Therapeutics Inc (FATE)
Proxy statement
Start not stated–2021-04-21
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Fate Therapeutics Inc (FATE) | Chief Scientific Officer | $375,000 | $2,818,586 |
Recent activity
No call appearances or filed executive changes recorded yet.